CLINICAL_TRIALS
trial_result
· 2021-03-19
Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines [Phase 2]
Summary
Phase 2 trial evaluating the efficacy and safety of MBA-P01 for treatment of lateral canthal lines has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medy-Tox | Conditions: Lateral Canthal Lines | Phase 2 | Status: COMPLETED